13 results
424B4
BHVN
Biohaven Ltd.
24 Oct 22
Prospectus supplement with pricing info
9:38am
then made efforts to progress antagonists of TRPA1, the receptor for mustard oil. Though Glenmark’s GRC 17536 showed encouraging results in a subset
S-1/A
BHVN
Biohaven Ltd.
20 Oct 22
IPO registration (amended)
10:00am
then made efforts to progress antagonists of TRPA1, the receptor for mustard oil. Though Glenmark’s GRC 17536 showed encouraging results in a subset
S-1
BHVN
Biohaven Ltd.
18 Oct 22
IPO registration
4:03pm
in study participants. Several companies then made efforts to progress antagonists of TRPA1, the receptor for mustard oil. Though Glenmark’s GRC 17536 showed
DRS
BHVN
Biohaven Ltd.
11 Oct 22
Draft registration statement
12:00am
-significant hyperthermia in study participants. Several companies then made efforts to progress antagonists of TRPA1, the receptor for mustard oil. Though
10-12B/A
EX-99.1
kl0a7eu tj
20 Sep 22
Registration of securities (amended)
6:30am
10-12B/A
EX-99.1
7moc834hs7s65
14 Sep 22
Registration of securities (amended)
5:25pm
10-12B/A
EX-99.1
ieb1 q40o838p71mzan
7 Sep 22
Registration of securities (amended)
7:26am
10-12B/A
EX-99.1
mna6rogqntk7igd
24 Aug 22
Registration of securities (amended)
5:03pm
10-12B
EX-99.1
qru8c
10 Aug 22
Registration of securities
5:07pm
10-12B
EX-2.2
b4hgwf85 iw08
10 Aug 22
Registration of securities
5:07pm
DRS
EX-99.1
6pl2ohcy23
1 Jul 22
Draft registration statement
12:00am
DRS
EX-2.2
q8ee4afc3vpj60muc3
1 Jul 22
Draft registration statement
12:00am
- Prev
- 1
- Next